Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers
- PMID: 12654688
- PMCID: PMC152496
- DOI: 10.1128/AAC.47.4.1439-1442.2003
Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers
Abstract
The penetration of 1 g of intravenous ertapenem once daily for 3 days in suction-induced skin blisters was evaluated. Ten forearm blisters were formed (n = 12) 12 h prior to the last dose. Concentrations of ertapenem in blister fluid exceeded 4 micro g/ml (the MIC at which 90% of the isolates tested are eliminated) for the entire dosing interval. The area under the concentration-time curve for 0 to 24 h ratio of blister fluid to plasma was 61% (90% confidence interval, 56, 65%) suggesting good blister penetration.
Figures
Similar articles
-
Pharmacokinetics of ertapenem in healthy young volunteers.Antimicrob Agents Chemother. 2002 Nov;46(11):3506-11. doi: 10.1128/AAC.46.11.3506-3511.2002. Antimicrob Agents Chemother. 2002. PMID: 12384357 Free PMC article. Clinical Trial.
-
Pharmacokinetics of intramuscularly administered ertapenem.Antimicrob Agents Chemother. 2003 May;47(5):1732-5. doi: 10.1128/AAC.47.5.1732-1735.2003. Antimicrob Agents Chemother. 2003. PMID: 12709348 Free PMC article. Clinical Trial.
-
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.J Antimicrob Chemother. 2006 Sep;58(3):632-6. doi: 10.1093/jac/dkl284. Epub 2006 Jul 12. J Antimicrob Chemother. 2006. PMID: 16840426 Clinical Trial.
-
Ertapenem: a new carbapenem.Expert Opin Investig Drugs. 2001 Jun;10(6):1157-66. doi: 10.1517/13543784.10.6.1157. Expert Opin Investig Drugs. 2001. PMID: 11772242 Review.
-
Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects.Drugs Today (Barc). 2002 Mar;38(3):195-213. doi: 10.1358/dot.2002.38.3.820127. Drugs Today (Barc). 2002. PMID: 12532175 Review.
Cited by
-
The treatment of diabetic foot infections: focus on ertapenem.Vasc Health Risk Manag. 2009;5:949-63. doi: 10.2147/vhrm.s3162. Epub 2009 Nov 16. Vasc Health Risk Manag. 2009. PMID: 19997576 Free PMC article. Review.
-
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I.Antibiotics (Basel). 2022 Aug 29;11(9):1164. doi: 10.3390/antibiotics11091164. Antibiotics (Basel). 2022. PMID: 36139944 Free PMC article. Review.
-
Comparative review of the carbapenems.Drugs. 2007;67(7):1027-52. doi: 10.2165/00003495-200767070-00006. Drugs. 2007. PMID: 17488146 Review.
-
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.Clin Pharmacokinet. 2006;45(8):755-73. doi: 10.2165/00003088-200645080-00001. Clin Pharmacokinet. 2006. PMID: 16884316 Review.
-
Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery.Antimicrob Agents Chemother. 2016 Dec 27;61(1):e00952-16. doi: 10.1128/AAC.00952-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27795367 Free PMC article.
References
-
- Bergan, T. 1981. Pharmacokinetics of tissue penetration of antibiotics. Rev. Infect. Dis. 3:45-66. - PubMed
-
- Bruun, J. N., J. E. Bredesen, P. Kierulf, and P. K. M. Lunde. 1991. Pharmacokinetic studies of antibacterial agents using the suction blister method. Scand. J. Infect. Dis. 74(Suppl.):49-53. - PubMed
-
- Hellum, K. B., A. Schreiner, A. Digranes, and I. Bergman. 1978. Skin blisters produced by suction: a new model for studies of penetration of antibiotics in humans, p. 620-622. In W. Siegenthaler and R. Lüthy (ed.), Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, vol. I. American Society for Microbiology, Washington, D.C.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical